))
DME/Retina Edition: Top Headlines for Week of September 9, 2024
Manage episode 439584622 series 3560281
محتوای ارائه شده توسط Healio. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Healio یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here:
Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema
OCT, visual acuity popular benchmarks in clinical practice guidelines for DME
First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema
OCS-01 eye drop for DME in second stage of phase 3 trial
Q&A: Susvimo delivers immediate durability after implantation in wet AMD
References:
Crawford C. Update on OCS-01: A novel topical drop for DME in phase 3 trials. Presented at: Clinical Trials at the Summit; June 8, 2024; Park City, Utah.
Healio Interviews
McAllister M, et al. Assessing the strength of clinical practice guidelines for managing diabetic macular edema — A systematic literature review. Presented at: American Society of Retina Specialists annual meeting; July 17-20, 2024; Stockholm.
120 قسمت
اشتراک گذاری
